CD19 and diffuse large B-cell lymphoma: A recent study has also shown that high bacterial abundances of Dorea in the gut microbiome are linked to expansion, immune checkpoint expression, and efficacy of CD19-directed CAR T-cells in patients with relapsed/refractory Diffuse-Large B-Cell Lymphoma (75).